Home/Filings/4/0001144204-12-026375
4//SEC Filing

ROSENDALE MARTIN P 4

Accession 0001144204-12-026375

CIK 0001091596other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:02 PM ET

Size

9.5 KB

Accession

0001144204-12-026375

Insider Transaction Report

Form 4
Period: 2012-05-03
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Exercise of In-Money

    Common Stock

    2012-05-03$0.54/sh+17,922$9,621150,251 total
  • Exercise of In-Money

    Warrant

    2012-05-0317,9221,076,259 total
    Common Stock (17,922 underlying)
  • Purchase

    Warrant

    2012-05-03+4,0711,080,330 total
    Exercise: $1.42Exp: 2014-12-31Common Stock (4,071 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock of the Company issued upon exercise of an in-the-money warrant issued in connection with the April 2010 private placement. The exercise price per share of such warrant is $0.5368. The warrant was exercisable immediately and expires on April 9, 2015.
  • [F2]30% of the shares of the Company's common stock issuable under the warrant are exercisable immediately on the issuance date, and the remaining portion upon issuance of the last portion of the post-closing consideration to be issued in connection with the February 2012 Aldagen acquisition.

Issuer

CYTOMEDIX INC

CIK 0001091596

Entity typeother

Related Parties

1
  • filerCIK 0001430354

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:02 PM ET
Size
9.5 KB